These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30334473)

  • 1. How to make P-glycoprotein (ABCB1, MDR1) harbor mutations and measure its expression and activity in cell cultures?
    Zubiaur P; Saiz-Rodríguez M; Koller D; Ovejero-Benito MC; Wojnicz A; Abad-Santos F
    Pharmacogenomics; 2018 Nov; 19(16):1285-1297. PubMed ID: 30334473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.
    Zhou SF
    Xenobiotica; 2008 Jul; 38(7-8):802-32. PubMed ID: 18668431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of ABCB1 (MDR1) gene polymorphism and P-glycoprotein inhibitors on digoxin serum concentration in congestive heart failure patients.
    Kurzawski M; Bartnicka L; Florczak M; Górnik W; Droździk M
    Pharmacol Rep; 2007; 59(1):107-11. PubMed ID: 17377214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional evaluation of ABCB1 (P-glycoprotein) polymorphisms: high-speed screening and structure-activity relationship analyses.
    Ishikawa T; Hirano H; Onishi Y; Sakurai A; Tarui S
    Drug Metab Pharmacokinet; 2004 Feb; 19(1):1-14. PubMed ID: 15499164
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Jiang B; Yan LJ; Wu Q
    DNA Cell Biol; 2019 May; 38(5):485-490. PubMed ID: 30977678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCB1 single nucleotide polymorphisms (1236C>T, 2677G>T, and 3435C>T) do not affect transport activity of human P-glycoprotein.
    Dickens D; Owen A; Alfirevic A; Pirmohamed M
    Pharmacogenet Genomics; 2013 Jun; 23(6):314-23. PubMed ID: 23619510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression.
    Sarginson JE; Lazzeroni LC; Ryan HS; Ershoff BD; Schatzberg AF; Murphy GM
    Pharmacogenet Genomics; 2010 Aug; 20(8):467-75. PubMed ID: 20555295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of ABCB1 (1236C > T, 2677G > T and 3435C > T) polymorphisms on the transport ability of P-gp-mediated sunitinib in Caco-2 cell line.
    Tan DQ
    Xenobiotica; 2020 Mar; 50(3):346-353. PubMed ID: 31023123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCB1 genetic polymorphisms affect opioid requirement by altering function of the intestinal P-glycoprotein.
    Qin W; Zhang L; Wang X; Liu B; Xu L; Liu L; Fan B
    Biomed Pharmacother; 2024 Jul; 176():116897. PubMed ID: 38850645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.
    Uhr M; Tontsch A; Namendorf C; Ripke S; Lucae S; Ising M; Dose T; Ebinger M; Rosenhagen M; Kohli M; Kloiber S; Salyakina D; Bettecken T; Specht M; Pütz B; Binder EB; Müller-Myhsok B; Holsboer F
    Neuron; 2008 Jan; 57(2):203-9. PubMed ID: 18215618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers.
    Ansermot N; Rebsamen M; Chabert J; Fathi M; Gex-Fabry M; Daali Y; Besson M; Rossier M; Rudaz S; Hochstrasser D; Dayer P; Desmeules J
    Drug Metab Lett; 2008 Apr; 2(2):76-82. PubMed ID: 19356075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter Haplotypes of the ABCB1 Gene Encoding the P-Glycoprotein Differentially Affect Its Promoter Activity by Altering Transcription Factor Binding.
    Speidel JT; Xu M; Abdel-Rahman SZ
    DNA Cell Biol; 2018 Dec; 37(12):973-981. PubMed ID: 30277801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
    Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
    Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of MDR1 gene polymorphism (2677G>T) on expression and function of P-glycoprotein at the blood-brain barrier: utilizing novel P-glycoprotein humanized mice with mutation.
    Yamasaki Y; Moriwaki T; Ogata S; Ito S; Ohtsuki S; Minegishi G; Abe S; Ohta Y; Kazuki K; Kobayashi K; Kazuki Y
    Pharmacogenet Genomics; 2022 Oct; 32(8):288-292. PubMed ID: 35997049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics of drug transporters: a new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1).
    Ishikawa T; Onishi Y; Hirano H; Oosumi K; Nagakura M; Tarui S
    Biol Pharm Bull; 2004 Jul; 27(7):939-48. PubMed ID: 15256718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure.
    Vandell AG; Lee J; Shi M; Rubets I; Brown KS; Walker JR
    Pharmacogenomics J; 2018 Jan; 18(1):153-159. PubMed ID: 27897269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein mechanical functional analysis using in silico molecular modeling: Pharmacokinetic variability according to ABCB1 c.2677G > T/A genetic polymorphisms.
    Jeong SH; Jang JH; Lee YB
    Int J Biol Macromol; 2023 Sep; 249():126777. PubMed ID: 37683742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.
    Ray A; Tennakoon L; Keller J; Sarginson JE; Ryan HS; Murphy GM; Lazzeroni LC; Trivedi MH; Kocsis JH; DeBattista C; Schatzberg AF
    Pharmacogenomics J; 2015 Aug; 15(4):332-9. PubMed ID: 25487678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition.
    Haufroid V
    Curr Drug Targets; 2011 May; 12(5):631-46. PubMed ID: 21039333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents.
    Woodahl EL; Crouthamel MH; Bui T; Shen DD; Ho RJ
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):183-8. PubMed ID: 19123050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.